Revenue growth masks 35% PAT collapse; margin recovery depends on price-pass timing
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit Q1 revenue target (19% vs 19% delivered), but missed EBITDA margin guide (5.4% actual vs 7-8% target). Margin miss is material (280 bps). Price hikes initiated July 15 were reactive, not proactive.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong volume and revenue growth (+19% YoY, record ₹1,198 Cr) masks a structural margin collapse: PAT crashed 35% YoY to ₹41 Cr, EBITDA margin fell 280 bps to 5.4% vs 8.2% prior year. Management attributes this to temporary procurement inflation and gradual pricing—but the real issue is execution lag: procurement costs rose ₹3.9/liter YoY while milk prices only rose ₹2.2/liter, a 44% shortfall. Margin recovery depends entirely on successful price pass-through from Q2 onwards, which remains unproven as of call date (late July).
₹1198 Cr
Revenue · +19% YoY₹41 Cr
Reported PAT · −35.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Margin pressure is cyclical, expect recovery Q2 onwards
OVERSTATEDEBITDA margin collapsed to 5.4% vs 8.2% a year ago; 280 bps decline. Q1 YoY PAT fell 35.4%
Prices not fully passed, will gradually pass to consumers in forthcoming quarters
MISSMilk sales price only rose ₹2.2/liter YoY despite ₹3.9/liter procurement cost hike. Pricing lagged 44% of cost inflation
Highest-ever quarterly revenue of ₹1,198 crores, 19% YoY
METDelivered ₹1,197.9 Cr, 19.0% YoY growth confirmed
India standalone milk procurement grew (ex-OSAM only 3%)
METAnalysts pressed hard: India DDL only 3% volume growth vs prior 8-9%. Africa & Maharashtra drove blended 13% growth
VAP highest-ever sales of ₹415 crores, 17.6% growth; ex-bulk 40.6% growth
METConfirmed ₹414.7 crores VAP ex-bulk, 40.6% LTL growth supported
Africa delivered ₹154 crores revenue, 45.6% growth, EBITDA ₹24 crores up 74%
METCall confirms both revenue and EBITDA figures and growth rates
Earnings quality
What changed since the last call
EBITDA margin guidance credibility
DowngradePrior 7-8% target; Q1 delivered 5.4%. Management now says recovery from Q2. Guidance track record weakened by 280 bps miss
India standalone growth trajectory
DowngradeCore India DDL procurement only 3% YoY (ex-OSAM). Prior implied 8-10%. Slowdown driven by pricing strategy (not expanding in high-price geographies like Andhra)
Margin recovery timeline
NeutralStill expect 7-8% by EoFY27, but now emphasize gradual pass-through from Q2. Q1 miss pushed recovery date out by 1 quarter
Africa & VAP outlook
UpgradeProcurement network quality
NeutralEmphasize Maharashtra +10%, but India overall 3% and selective growth (not expanding in Andhra due to competitive pricing). Supplier relationships strong but geog expansion cautious
The Q&A
Analysts pressed hard on three fronts: (1) Core India growth slowdown (Praveen Kumar, ICICI, others noted only 3% ex-OSAM vs prior 8-9%); (2) Timing of margin recovery (Aniruddha Joshi asked 'is worst behind?', management hedged); (3) Procurement data clarity (analyst forced management to break down OSAM, Africa, India separately; revealed India nearly flat). Management held up on Africa growth & VAP, but conceded pricing lagged cost inflation. Tone defensive but not evasive.
Margin trajectory — Praveen Kumar, Equitas Capital
PartialConfident 7-8% EBITDA maintained despite cyclical pressure; seasonal, not structural reset. Price pass-through underway
Procurement growth ex-OSAM — Praveen Kumar, Equitas Capital
AnsweredAndhra, Karnataka maintained (not degrowthing) but not expanding due to high competitive pricing; strategy is selective. Maharashtra +10%, Africa +28%
Margin recovery credibility — Aniruddha Joshi, ICICI Securities
PartialAfrica & Orga done 70-80% already. Dodla still catching up; took ₹1+ hike in May, ₹2 more in July, plan 2.5% in Q2. Most corrections done
Ice cream capex appetite — Aniruddha Joshi, ICICI Securities
AnsweredNo major expansion planned; growing from ₹16 Cr to ₹22 Cr Q1 on existing capacity. Wait & see this year; plan later
Milk price hike quantum — Darshita Shah, DSP Asset Managers
AnsweredPlan 2-2.5% more in Q2, targeting 4-5% for full year on milk. Blended (VAP) will be higher
Volume growth resilience — Darshita Shah, DSP Asset Managers
AnsweredYes, target maintained 8-10% volume growth; pricing passed gradually, so growth continues
Competitive pricing landscape — Yash Goenka, Awriga Capital
AnsweredAmul, Nandini taken ghee/milk hikes. National cooperatives will follow. TN gap ₹10+, KA gap ₹6-7. We took ₹2 avg across regions
Procurement cost normalization — Abhishek Mathur, Systematix Group
PartialNormalization = no decline expected, just stabilization at ₹41/liter. May-June-July all flat around ₹41.20. No seasonal drop yet
Milk sales volume slowdown — Aditya, Securities Investment Management
PartialSummer months, milk demand lower (shift to VAP). Africa milk +33% YoY. India milk 10.4L (seasonal). Normal trend resuming Q2
Execution priorities Q2+ — Sucrit Patil, EyeSight Fintrade
PartialAfrica on track to hit 100% targets (volume & EBITDA). Feed 25%+ growth. DDL already corrected pricing from mid-July. El-Niño weather impact, but no structural inventory issue
Portfolio composition 3-year outlook — Abhishek Kanithi, Nivaka Ventures
AnsweredAfrica stays ~10% (won't surge further without acquisitions). VAP: maintain 10% volume growth targeting; DDL 70-80%, overseas 15%, OSAM 8-10%
India core market growth headwinds — Bhavesh Jain, DD Investment Advisors
AnsweredCore markets: maintain share, not push given high cooperatives gaps (TN, KA). Maharashtra milk balancing only 2L local sales. Geographic rotation strategy. 10% blended target
Direct farmer payment & productivity — Manish Jain, GormalOne LLP
Answered100% direct farmer payment (nearly). Animal data hard to track; farmer avg increasing steadily. Dodla feed users do 14L vs non-users 11L per farmer
Guidance
FY27 consolidated 15% revenue growth (10% volume + 5% pricing/mix)
MediumAssumes continued India momentum + Africa scaling. Price hikes 4-5% target achievable but dependent on competitive landscape & demand elasticity
EBITDA 7-8% range FY27; recovery from Q2 onwards after Q1 cyclical 5.4%
MediumGradual pass-through of ₹2-2.5% milk + 3-4% VAP hikes Q2-Q3 expected to recover margin. Assumes procurement stabilizes at current ₹41/L
₹590 Cr capex (Maharashtra Greenfield, OSAM scale, Africa expansion) funded from internal accruals
HighNo leverage needed; ₹689 Cr cash sufficient. Maharashtra on timeline, Kenya utilization ramping 80%, Uganda full capacity planned Greenfield
Risks the call surfaced
Pricing power erosion
MediumDodla's ₹10+ price gap in TN, ₹6-7 in KA vs cooperatives will narrow if Amul/Mother Dairy take hikes. Current 4-5% FY27 hike plan may face volume pushback
Procurement cost persistence
HighMilk procurement costs elevated at ₹41.3/L vs ₹37.4/L prior year. Management expects normalization but says May-June-July all flat ~₹41.20/L. If monsoon disruption continues, prices stay high, margin recovery delayed
Core India DDL growth stalling
MediumIndia DDL standalone milk procurement only 3% YoY (ex-OSAM). Analysts noted growth has slowed from prior 8-9%. Geographic expansion constrained by high cooperatives pricing (TN, KA) and selective capacity strategy
Margin miss credibility
HighQ1 EBITDA margin 5.4% vs 7-8% prior guidance (280 bps miss). Management blamed cyclical/seasonal pressure and pricing lag, but recovery now pushed to Q2+. If Q2 misses again, credibility erodes; investor sentiment on margin recovery guidance would deteriorate
Working capital inventory risk
LowIf procurement costs stay elevated and milk supply remains muted (not flushing), company may need to build inventory or become net buyer at high prices, stressing working capital. However, ₹689 Cr cash provides buffer
Management
Score 6/10. Transparent on numbers but narrative tries to minimize margin miss. Admitted pricing lag but framed as strategy (gradual pass-through vs lump-sum hikes). Candid on geographic constraints (high pricing in TN/KA limits expansion). Some NDA shielding on Sids Farm investment rationale (vague 'learning' language) Mixed. Hit revenue growth targets (+19% YoY on track for 15% guidance) but MISSED EBITDA margin target materially (5.4% vs 7-8%, 280 bps shortfall). Pricing lag relative to procurement inflation (₹2.2 vs ₹3.9 hike) indicates reactive vs proactive execution. However, Africa & VAP delivering well
1 · Q2 FY27 (Aug-Sep)
Price hike pass-through completion; procurement cost normalization post-monsoon
2 · Q2 FY27 onwards
Maharashtra Greenfield capex ramp; East India capacity/Chandel production shift
3 · H2 FY27
OSAM profitability inflection; Kenya processing capacity utilization towards 100%
Margin recovery depends entirely on successful price pass-through from Q2 onwards, which remains unproven as of call date (late July).
Informational and educational content only. Not investment advice.